Zhijiang Biotech (688317.SH) announced semi-annual results, with a net loss of 40.59 million yuan

According to Zhitong Finance App News, Zhijiang Biotech (688317.SH) disclosed the 2026 semi-annual report. During the reporting period, the company achieved operating income of 53.39 million yuan, a year-on-year decrease of 10.55%; net profit loss attributable to shareholders of listed companies was 45.21 million yuan, up year-on-year; net profit loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 45.21 million yuan, an increase over the previous year; and basic earnings per share were -0.23 yuan.

The total profit of the company during the reporting period, net profit attributable to shareholders of listed companies, and net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss were negative, and losses increased compared to the same period last year, mainly due to the increase in the company's exchange losses and the decline in sales revenue during the reporting period.